Pilot study of ceramide cream for the skin toxicity of cetuximab in advanced colorectal cancer.

Pilot study of ceramide cream for the skin toxicity of cetuximab in advanced colorectal cancer. - Pilot study of ceramide cream for the skin toxicity of cetuximab in advanced colorectal cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006578

Enrollment

Registered

2011-10-20

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

ceramide cream

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with skin toxicity of cetuximab uncontrolled with coventional therapy. 2) PS(ECOG) 0 or 1. 3) Patients who can use ceramide cream. 4) Patients who can respond to uestinnaire. 5) Agree with take the pictures of skin toxicity. 6) Life expectancy 3months over. 7)Written informed concent.

Exclusion criteria

Exclusion criteria: 1) Other causes occureing skin toxicity. 2) inappropriate for the study.

Design outcomes

Primary

Measure	Time frame
efficacy for skin toxicity	—

Secondary

Measure	Time frame
time to efficacy safety	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026